Skip to main content
GMED
NYSE Industrial Applications And Services

Globus Medical 10-Q: Q3 Sales Slip 0.7% to $763.7M, Buyback Raised $500M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$77.6
Mkt Cap
$10.934B
52W Low
$60.255
52W High
$101.398
52W Position info
29% above low
Off High info
23% below high
Rel. Volume info
2.8× avg
Market data snapshot near publication time

GMED sits 29% above its 52-week low of $60.255 on elevated volume (2.8× avg).

Summary

Globus Medical's Q3 10-Q details a 0.7% sales decline to $763.7M on weak spinal cord stimulation and international sales, offset by operating income of $177.6M and a newly expanded $500M buyback authorization.


Key Events · Earnings and Guidance · GMED

  • Q3 Sales Decline 0.7%

    Net sales were $763.7M versus $769.0M a year ago; U.S. rose 0.5% to $621.0M but international fell 5.7% to $142.7M, and spinal cord stimulation sales dropped $22.1M on lower U.S. trial volumes.

  • Operating Income Jumps to $177.6M

    Q3 operating income rose from $137.4M to $177.6M as cost of sales fell 7.8% to $232.9M and the litigation provision dropped $24.6M; nine-month operating income was $510.4M versus $310.5M.

  • Buyback Raised by $500M

    On November 2, 2026 the board authorized an additional $500.0M of Class A repurchases, leaving roughly $611.0M available; Q3 repurchases were 1.9M shares for $142.9M at an average $74.61.

  • Cash Flow and Balance Sheet

    Nine-month operating cash flow was $677.3M versus $504.9M, with $441.3M of cash and equivalents plus $76.2M short-term and $353.7M long-term marketable securities at September 30, 2026.


Analysis · GMED · Industrial Applications And Services

The headline numbers were already out hours earlier, but the full 10-Q shows where the quarter actually went: U.S. sales grew just 0.5% to $621.0M while international fell 5.7% to $142.7M, and spinal cord stimulation revenue dropped $22.1M on weaker U.S. trial volumes. Profitability still improved sharply, with Q3 operating income of $177.6M versus $137.4M a year ago, helped by lower cost of sales and a $24.6M smaller litigation provision. Cash generation is strong at $677.3M for nine months, and the board added $500.0M to the buyback on November 2, 2026, leaving about $611.0M available — a real offset to the revenue guidance cut disclosed in the concurrent 8-K.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GMED was trading at $77.60 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $10.9B. The 52-week trading range was $60.26 to $101.40. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GMED - Latest Insights

GMED
Nov 05, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $80.31
Real-time Price: $66.89 info
Change: -$13.42 (-17%) info
Market Cap: $8.861B info
GMED
Nov 05, 2026, 4:02 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $81.52
Real-time Price: $66.89 info
Change: -$14.63 (-18%) info
Market Cap: $8.861B info
GMED
Nov 03, 2026, 4:02 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $79.58
Real-time Price: $66.89 info
Change: -$12.69 (-16%) info
Market Cap: $8.861B info
GMED
Aug 26, 2026, 5:57 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $82.96
Real-time Price: $66.89 info
Change: -$16.07 (-19%) info
Market Cap: $8.861B info
GMED
Aug 06, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $84.00
Real-time Price: $66.89 info
Change: -$17.11 (-20%) info
Market Cap: $8.861B info